Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Cancer Science|December 1, 2011
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donorsSoyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Journal of Neurosurgery|May 2, 2008
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiformeShuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, et al.
Anticancer Research|July 24, 2010
A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccinationFumihiro Fujiki, Yoshihiro Oka, Mai Kawakatsu, et al.
International Journal of Cancer|May 13, 2016
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptideYusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, et al.
Journal of Neurosurgery|December 2, 2016
Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401)Takuya Kawabe, Masaaki Yamamoto, Yasunori Sato, et al.
British Journal of Cancer|November 17, 2023
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, et al.
Journal of Neuro-Oncology|March 21, 2018
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastomaToshihiko Wakabayashi, Atsushi Natsume, Junki Mizusawa, et al.
Journal of Neuro-Oncology|May 6, 2020
Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide aloneAtsushi Natsume, Kosuke Aoki, Fumiharu Ohka, et al.
Acta Neuropathologica Communications|July 26, 2024
Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohortNobuhide Hayashi, Junya Fukai, Hirokazu Nakatogawa, et al.
Pageof 17